Sedatives

Conestoga Constructs GNS Units

Retrieved on: 
Tuesday, April 27, 2021

b'LIBERAL, Kan., April 27, 2021 (GLOBE NEWSWIRE) -- Conestoga today announced it has expanded production capabilities to produce grain neutral spirits that exceed US Pharmacopeia (USP) specification.

Key Points: 
  • b'LIBERAL, Kan., April 27, 2021 (GLOBE NEWSWIRE) -- Conestoga today announced it has expanded production capabilities to produce grain neutral spirits that exceed US Pharmacopeia (USP) specification.
  • Conestoga is excited to\xc2\xa0begin providing high quality alcohols to meet the specifications of customers looking for sustainable ingredients for health, home, beauty, and pharmaceutical applications.\xc2\xa0 Bulk purchase options are now available from Guardian Ingredient Solutions, a Conestoga subsidiary.\nWith offices in Liberal, Kansas and Southlake, Texas, Conestoga is a renewable energy company focused on providing sustainable solutions to replace traditional petroleum-based products and ingredients.
  • With three ethanol plants in Kansas and Texas, Conestoga manages 200+ million gallons per year of low carbon biofuel production capacity, as well as corn processing, grain handling and storage.
  • Through its adjacent business activities, Conestoga produces high-protein feed products, as well as provides commodity marketing and logistics services.

doublEE's Multifunctional Solution Expands Applications of Portable Disinfectors

Retrieved on: 
Monday, April 26, 2021

Disinfecting, Charging and Watching Clips at the Same Moment

Key Points: 
  • Its story started in the early 2020, when the needs for disinfection surged to all-time highs.
  • "We had to roll out something different," said Mr. Keith Wu, the General Manager of doublEE.
  • "Though many UV disinfectors were available, after trying them twice people were often going back to wipes and ethanol.
  • The size of electronic devices which undergo wireless charging is no longer restricted by the chamber size.

Global Ethyl Alcohol and Other Basic Organic Chemical Market Report 2021: COVID-19 Impact and Recovery to 2030 Featuring ADM Company; DowDuPont Inc; Celanese and Raizen - ResearchAndMarkets.com

Retrieved on: 
Monday, April 26, 2021

The market is expected to reach $1096.2 billion in 2025 at a CAGR of 4%.\nAsia Pacific was the largest region in the global ethyl alcohol and other basic organic chemical market, accounting for 57% of the market in 2020.

Key Points: 
  • The market is expected to reach $1096.2 billion in 2025 at a CAGR of 4%.\nAsia Pacific was the largest region in the global ethyl alcohol and other basic organic chemical market, accounting for 57% of the market in 2020.
  • Western Europe was the second largest region accounting for 16% of the global ethyl alcohol and other basic organic chemical market.
  • Africa was the smallest region in the global ethyl alcohol and other basic organic chemical market.\nChemical companies are increasingly using automation and instrumentation solutions to control the production process more effectively.
  • Ethyl alcohol used for fuel is being blended into gasoline at concentrations of 5% to 10%.

DGAP-News: doublEE : doublEE's Multifunctional Solution Expands Applications of Portable Disinfectors

Its story started in the early 2020, when the needs for disinfection surged to all-time highs.

Key Points: 
  • Its story started in the early 2020, when the needs for disinfection surged to all-time highs.
  • "We had to roll out something different," said Mr. Keith Wu, the General Manager of doublEE.
  • "Though many UV disinfectors were available, after trying them twice people were often going back to wipes and ethanol.
  • The size of electronic devices which undergo wireless charging is no longer restricted by the chamber size.

The Power of the Platform in Psychedelic Medicine

Retrieved on: 
Tuesday, April 20, 2021

OTC Stock Review introduced a large number of investors to the psychedelic sector with an article on Seeking Alpha March 6, 2020 titled " Psychedelic Medicine Stocks Capture the Attention of Investors ."

Key Points: 
  • OTC Stock Review introduced a large number of investors to the psychedelic sector with an article on Seeking Alpha March 6, 2020 titled " Psychedelic Medicine Stocks Capture the Attention of Investors ."
  • MindMed recently announced it would establish a digital medicine division known as Albert to research, develop and build an integrated technical platform and comprehensive toolset aimed at delivering psychedelic inspired medicines and experiential therapies combined with digital therapeutics.
  • It is a data driven platform that has been strategically developed to provide better communication among medical practitioners and health care providers.
  • Ehave\'s Dashboard is also a key component of its ketamine home delivery platform known as KetaDASH www.ketadash.com.

PharmaTher Announces Submission of IND Application with the FDA for Phase 2 Clinical Trial Evaluating Ketamine in the Treatment of Parkinson’s Disease

Retrieved on: 
Tuesday, April 20, 2021

Parkinson\xe2\x80\x99s disease and Lou Gehrig\xe2\x80\x99s disease), mental illness (ie.

Key Points: 
  • Parkinson\xe2\x80\x99s disease and Lou Gehrig\xe2\x80\x99s disease), mental illness (ie.
  • The possible therapeutic effect of low-dose ketamine on LID was noted in a retrospective analysis of PD patients who received ketamine for pain relief.
  • During this analysis, it was observed that the patients experienced an improvement in LID lasting several weeks beyond treatment [Sherman et al, 2016].
  • The primary end-point of the study is the change in the Unified Dyskinesia Rating Scale (\xe2\x80\x9cUDysRS\xe2\x80\x9d) total score from Baseline to Week 8.

OVID Provides Update on OV101 Program and the Prioritization of its Resources

Retrieved on: 
Monday, April 19, 2021

As part of this update, Ovid will discontinue development of OV101 (gaboxadol), a delta (\xce\xb4)-selective GABAA\xc2\xa0receptor agonist, in Angelman syndrome.

Key Points: 
  • As part of this update, Ovid will discontinue development of OV101 (gaboxadol), a delta (\xce\xb4)-selective GABAA\xc2\xa0receptor agonist, in Angelman syndrome.
  • Furthermore, Ovid does not plan to initiate further clinical studies of OV101 in Fragile X syndrome.
  • \xe2\x80\x9cWhile we are disappointed in the outcome for OV101, our resources are now squarely focused on a very promising pipeline in rare neurological diseases, including Angelman syndrome.
  • Ovid assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available.\n'

Cannabis Extraction Industry Catches a Much Needed Break

Retrieved on: 
Thursday, April 22, 2021

That\'s the motto ofSimple Solvents.\nThe chemical industry was thrown into chaos during the COVID-19 pandemic.

Key Points: 
  • That\'s the motto ofSimple Solvents.\nThe chemical industry was thrown into chaos during the COVID-19 pandemic.
  • This specific formula allows for extraction companies to avoid the $27.00/gallon excise tax on pure, undenatured 200 proof ethanol.\nCeres 14 Inc. owns the SIMPLE SOLVENTS brand.
  • Ceres 14\'s focus on customer service, transparency, and expertise in the cannabis industry will be a tremendous complement to MRE\'s ability to cost effectively manufacture a diverse array of quality ethanol products.
  • It is exactly what the cannabis industry needs."

Eco-Energy Commences Construction on its Stockton, California Ethanol Distribution Terminal

Retrieved on: 
Tuesday, April 20, 2021

b'Eco-Energy, a leading biofuel supply chain company, is pleased to announce that it has started construction on its ethanol distribution facility located in Stockton, California.

Key Points: 
  • b'Eco-Energy, a leading biofuel supply chain company, is pleased to announce that it has started construction on its ethanol distribution facility located in Stockton, California.
  • The facility is scheduled to commence operations in March 2022 and will be the eleventh (11th) ethanol distribution terminal constructed by Eco-Energy over the past decade.
  • The Stockton site will be equipped with 108 tank car offload spots, 6.7 million gallons of dedicated ethanol storage and high-speed truck loading capability.
  • This project again highlights our team\xe2\x80\x99s ability to collaborate, align incentives, and generate clear value-add throughout the supply chain,\xe2\x80\x9d says Eco-Energy CEO, Craig Willis.

Innospec Introduces Next Generation Ethanol Corrosion Inhibitor And pHe Buffer DCI-11 PLUS ClearTrak ™ With Breakthrough Colorless Marker

Retrieved on: 
Tuesday, April 20, 2021

b'ENGLEWOOD, Colo., April 20, 2021 /PRNewswire/ -- Innospec Fuel Specialties (IFS), a division of Innospec Inc. (NASDAQ:IOSP), is pleased to announce its DCI-11 PLUS ClearTrakEthanol Corrosion Inhibitor and pHe Buffer now contains the industry\'s first colorless marker technology and no aromatics, often required for ethanol exports.

Key Points: 
  • b'ENGLEWOOD, Colo., April 20, 2021 /PRNewswire/ -- Innospec Fuel Specialties (IFS), a division of Innospec Inc. (NASDAQ:IOSP), is pleased to announce its DCI-11 PLUS ClearTrakEthanol Corrosion Inhibitor and pHe Buffer now contains the industry\'s first colorless marker technology and no aromatics, often required for ethanol exports.
  • "Having a colorless marker in your corrosion inhibitor provides a clear benefit for our customers," adds Vali Jerome, Vice President, Global Business Operations.
  • "\nMarketed as a multifunctional oxygenate additive with corrosion inhibitor and enhanced amine buffer that includes a colorless marker for easy customer treat rate verification and no aromatics, DCI-11 PLUS ClearTrak addresses multiple concerns in ethanol.
  • In addition to its Fuel Specialties group, the company\'s other business segments are Oilfield Services and Performance Chemicals.\nDCI-11 Plus ClearTrak is a trademark of Innospec Inc.\n'